Fondazione Oncologia Lago Maggiore
About Fondazione Oncologia Lago Maggiore
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Breast Cancer Trials, Australia and New Zealand
1
ETOP IBCSG Partners Foundation
1
Genentech, Inc.
1
Swiss Group for Clinical Cancer Research
1
Clinical Trials at Fondazione Oncologia Lago Maggiore
During the past decade, Fondazione Oncologia Lago Maggiore conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
2014-11-12
2017-03-13
Completed
334
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
2017-08-21
2023-12-01
Recruiting
1,167
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
2019-08-27
2026-11-01
Recruiting
400
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Oncologia Lago Maggiore"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Fondazione Oncologia Lago Maggiore
According to Clinical.Site data, the most researched conditions in "Fondazione Oncologia Lago Maggiore" are
"Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Cancer Recurrent" (1 trials) and "Early Stage Breast Carcinoma" (1 trials). Many other conditions were trialed in "Fondazione Oncologia Lago Maggiore" in a lesser frequency.
Clinical Trials Intervention Types at Fondazione Oncologia Lago Maggiore
Most popular intervention types in "Fondazione Oncologia Lago Maggiore" are "Drug" (3 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Letrozole" (1 trials), "Omission of radiation therapy" (1 trials), "Palbociclib 125mg" (1 trials), "Placebo" (1 trials) and "Standard endocrine therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fondazione Oncologia Lago Maggiore
The vast majority of trials in "Fondazione Oncologia Lago Maggiore" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Fondazione Oncologia Lago Maggiore
Currently, there are NaN active trials in "Fondazione Oncologia Lago Maggiore".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Fondazione Oncologia Lago Maggiore,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fondazione Oncologia Lago Maggiore, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".